Log in or Sign up for Free to view tailored content for your specialty!
Cardiology News
The false promise of personalized medicine in the global environment
Physicians listen to the patient in front of us. We care for one patient at a time. There is inherent individualization in the patient interaction. Each story is unique. Each treatment plan is tailored.
'Cutting edge' AI could help diagnose heart attacks
An algorithm that was developed with the help of artificial intelligence could help physicians diagnose myocardial infarction more quickly and accurately, according to the results of research published in Nature Medicine.
Log in or Sign up for Free to view tailored content for your specialty!
Top in cardiology: Irregular menstruation linked to CVD; heart disease risk scores
Women were more likely to develop CVD or atrial fibrillation if they had irregular menstrual cycles — shorter than 21 days or longer than 35 days — in a prospective study of UK Biobank data, researchers reported.
‘It takes a village’ to manage cardiovascular disease in patients with IMIDs
Properly managing cardiovascular disease in patients with immune-mediated inflammatory diseases requires following guidelines and inter-specialty collaboration, according to a speaker at the Biologic Therapies Summit.
Top in cardiology: Alirocumab ruling; trials target lipoprotein(a)
A unanimous U.S. Supreme Court decision has allowed Regeneron and Sanofi to continue selling alirocumab after Amgen alleged they infringed two of its patents for PCSK9 inhibitor technology.
Healthy low-fat diet reduces risks for all-cause, cardiovascular mortality
Healthy low-fat diets were associated with lower risks for all-cause and cardiovascular mortality, whereas overall and unhealthy low-carbohydrate diets were linked to increased risks, according to researchers.
Supreme Court decision allows alirocumab to stay on US market
The U.S. Supreme Court unanimously ruled in favor of Regeneron and Sanofi that two of Amgen’s patents for PCSK9 inhibitor technology were invalid, allowing alirocumab to stay on the U.S. market.
WHO: Do not use non-sugar sweeteners for weight management
WHO has issued a new guideline recommending against the use of non-sugar sweeteners to lose weight, as available evidence suggests it “does not confer any long-term benefit in reducing body fat in adults or children,” the organization said.
Top in cardiology: Phone use and high BP risk; expanded indication for dapagliflozin
Greater mobile phone use for making or receiving calls was associated with a higher risk for high blood pressure, particularly in those with a genetic risk for hypertension, recent data show.
Ambulatory vs. clinic blood pressure better predicts CV, all-cause death
Blood pressure measures obtained through ambulatory monitoring were more informative about risk for all-cause death or cardiovascular death than conventional clinic blood pressure readings, researchers reported.